BCP Dermatological Corporation and Metro Drug, Inc. Philippines Partnership Made Easy with Dermablend
BCP Dermatological Corporation (BCP) and Metro Drug, Inc. (MDI) have recently signed an agreement last July 20, 2017. It was concluded that MDI will be the exclusive distributor of BCP’s flagship brand, Dermablend which is widely prescribed by Dermatologists, Pediatricians, Ob- Gynecologists and other medical practitioners in the country.
The contract signing was attended by Ms. Dina dela Paz Stalder, President and CEO and Ms. Lea Juan, Operations Manager of BCP together with MDI’s Chief Executive Mr. Jojit Aguilar and VP-Finance, Mr. Allan Tanlapco.
L-R: Ms. Flordeliz Sobremonte, Client Development Analyst of MetroDrug Inc. (MDI); Ms. Rea Manalili, Business Development and Principal Services Director of MDI; Ms. Dina Dela Paz-Stalder, President & CEO of BCP Dermatological Corporation; Mr. Jojit
Aguilar, Chief Executive of MDI; Mr. Allan Tanlapco, Vice President-Finance of MDI; Ms. Sheila Anne Caday, Operations Manager of Diana Stalder Skincare Center; and Ms. Lea Juan, Operations Manager of BCP
BCP Dermatological Corporation is a dynamic company focused on dermatologicals, both pharmaceuticals and cosmetics, providing solutions to every type of skin condition. On the other hand, Metro Drug, Inc. is a leading pharmaceutical distributor in the Philippines. With its partnership, quality products will be distributed nationwide, thus patient’s compliance will be an advantage. (more…)